3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
16
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Stomach Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Diabetes Mellitus, Insulin-Dependent, 12
2
Carcinoma, Non-Small-Cell Lung
2
Resectable MMR-deficient Solid Tumors
1
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Cancer Metastatic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Microsatellite Stable Rectal Carcinoma
1
Melanoma
1
Lymphoma
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Cancer Metastatic
1
Interventions
pembrolizumab
137
Cisplatin
75
Cetuximab
51
Carboplatin
49
Paclitaxel
39
Nivolumab
38
Radiotherapy
37
Docetaxel
34
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
25
Specimen Handling
20
Fluorouracil
20
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
13
Taxes
12
cemiplimab
11
Radiation
11
Ipilimumab
11
atezolizumab
10
Surgical Procedures, Operative
10
Drug Therapy
10
Biopsy
9
durvalumab
8
Radiosurgery
8
130-nm albumin-bound paclitaxel
8
tislelizumab
7
Standard of Care
7
Chemoradiotherapy
7
Albumin-Bound Paclitaxel
7
Immune Checkpoint Inhibitors
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
balstilimab
×
1 year
×
Clear all
No trials found.